Brief report · 29 Dec 2025
Conference abstractPublished 12 Sep 2011
Determinants and prognostic role of BNP in central Africans with congestive heart failure
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
B-type natriuretic peptide (BNP) is one of the most reliable biomarkers enabling a rapid bedside diagnosis and prognosis of congestive heart failure (CHF) in developed countries. Data related to BNP in sub-Saharan Africa is still lacking due to cost constraints. Th e aim of this study was to determine potential relationships between epidemiological features, symptoms, cardiometabolic risk factors, antioxidant biomarkers, white cell count, case fatality and BNP measurements. In univariate analysis, males, urban residences, excessive alcohol intake, coronary heart disease, dry cough, NYHA class 3-4 and mortality were defi ned by signifi cant and higher BNP levels. In bivariate analysis, neutrophils (r=0.286; P=0.047), total bilirubin (r=0.480; P?0.0001), direct bilirubin (r= 0.465; P?0.001), uric acid (r= 0.354; P=0.003), systolic blood pressure (r=-0.226; P=0.029) BUN (r=0.320; P=0.005) and sodium(r=-0.580; P=0.028) showed signifi cant correlations with BNP levels, respectively. In multiple linear regression analysis and aft er adjusting for confounding factors, the independent determinants explaining 99.1% of variations (adjusted R2) of BNP levels were BUN, neutrophils and uric acid. Th e optimal cut-off point of BNP≥800 pg/mL obtained by ROC curve (AUC=0.819 95% CI0.710- 0.937, SE=0.061; P=0.003, sensitivity= 97.5% and specifi city=75.8%, conferred a relative Risk of case fatality =16.9 95% CI 2.2-31.3; P?0.001). Th us in countries with limited resources, the equation Y(BNP)=-4247 + 0.630* BUN + 0.552* neutrophils +0.287* uric acid and BNP≥ 800 pg/mL should be validated in large studies for the CHF management
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Molecular Biomarkers & Diagnosis.
Commentary · 29 Dec 2025
Molecular Diagnostics: Revolutionizing Precision Healthcare
Commentary · 29 Dec 2025
Genomic Biomarkers Revolutionizing Disease Diagnosis and Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Biomarkers & Diagnosis
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Longo-Mbenza B”
- BylineArticles whose byline prints “Forka AC”
- BylineArticles whose byline prints “Mouzenzo CM”
- BylineArticles whose byline prints “Kianu Phanzu B”
